TRICARE Coverage for GLP-1 (Ozempic, Wegovy, Mounjaro)
*TRICARE.com is an independent reference site and is not an official government platform. For official policy and individual benefit determinations, visit TRICARE.mil.*
## Quick answer TRICARE covers GLP-1 receptor agonists (like Ozempic, Wegovy, and Mounjaro) only when medically necessary for specific conditions. Currently, these medications are approved for the treatment of Type 2 Diabetes; weight loss versions (like Wegovy and Zepbound) are also covered but require strict prior authorization and proof of enrollment in a weight management program.
## In detail GLP-1 (glucagon-like peptide-1) medications have become highly sought after for both metabolic health and weight management. TRICARE’s coverage is managed by the pharmacy benefit manager, **Express Scripts**, and is divided into two main categories: Diabetes management and Weight Loss.
### 1. Type 2 Diabetes Treatment TRICARE covers GLP-1 drugs for the treatment of Type 2 Diabetes. Common medications in this category include: * **Ozempic** (semaglutide) * **Mounjaro** (tirzepatide) * **Victoza** (liraglutide) * **Trulicity** (dulaglutide)
**Clinical Requirements:** Generally, these require a Prior Authorization (PA). Providers must typically document that the patient has a diagnosis of Type 2 Diabetes and, in some cases, has tried other first-line treatments like Metformin without success.
### 2. Weight Loss/Anti-Obesity Treatment TRICARE covers specific GLP-1s explicitly FDA-approved for chronic weight management. These include: * **Wegovy** (semaglutide) * **Zepbound** (tirzepatide) * **Saxenda** (liraglutide)
**Coverage Criteria (2026 Standards):** To get these medications covered, your doctor must submit a Prior Authorization showing: * **BMI Requirements:** A Body Mass Index (BMI) of 30 or greater, OR a BMI of 27 or greater with at least one weight-related comorbidity (e.g., hypertension, high cholesterol). * **Program Participation:** Documentation that the beneficiary is currently participating in a behavioral modification program (lifestyle coaching, calorie restriction, and exercise). * **Contraindications:** Absence of pregnancy or history of medullary thyroid carcinoma.
### 3. Costs and Pharmacy Tiers (2026 Rates) Costs depend on the "tier" of the drug and where you fill it. Most GLP-1s are considered **Brand Name Formulary** drugs.
| Pharmacy Type | Copay (Formulary) | Copay (Non-Formulary) | | :--- | :--- | :--- | | **Military Pharmacy** | $0 | Not available | | **Home Delivery (90-day)** | $20–$35 | $68+ | | **Retail Network (30-day)** | $40–$50 | $75+ |
*Note: 2026 rates are subject to slight adjustments based on the National Defense Authorization Act (NDAA); check Express Scripts for the most current pricing.*
### 4. Step Therapy TRICARE often employs "Step Therapy," meaning you must try a lower-cost, preferred medication before they will pay for a more expensive GLP-1. If you are seeking Zepbound, they may require you to try Wegovy or Saxenda first, depending on current formulary preferences.
## Who this applies to * **Active Duty Service Members (ADSMs):** Require a referral and medical necessity documentation. Use of weight loss meds may impact fitness-for-duty status. * **Active Duty Family Members (ADFMs):** Covered under Prime or Select with a valid Prior Authorization and prescription. * **Retirees and their Families:** Covered, though copays are higher than for active-duty families. * **TRICARE For Life (TFL) Beneficiaries:** TRICARE acts as the primary payer for pharmacy benefits regardless of Medicare status, though GLP-1 coverage criteria remain strict.
Common scenarios
**Scenario 1: Type 2 Diabetes Diagnosis** John, a retired Navy petty officer using TRICARE Select, is diagnosed with Type 2 Diabetes. His doctor prescribes **Ozempic**. Because John has a documented diagnosis, the Prior Authorization is approved. He pays a **$40 copay** (2026 rate) for a 30-day supply at a local retail network pharmacy like Walgreens.
**Scenario 2: Weight Loss without Diabetes** Sarah, an Army spouse, has a BMI of 32 and wants to start **Wegovy**. Her doctor submits a Prior Authorization. TRICARE requires proof that Sarah has been in a weight management program for at least six months. Once approved, Sarah uses **Express Scripts Home Delivery** to get a 90-day supply for a **$35 copay** (2026 rate).
**Scenario 3: Off-label use** Mark wants to use Mounjaro for weight loss because he heard it works better than Wegovy. However, Mounjaro is only FDA-approved for diabetes. TRICARE denies the claim because they do not cover "off-label" use of diabetes meds for weight loss. Mark must switch to **Zepbound** (the weight-loss version of the same drug) and meet the weight-loss PA criteria.
## Related terms * **Prior Authorization (PA):** A requirement that your provider gets approval from TRICARE/Express Scripts before the drug is covered. * **Formulary:** The list of generic and brand-name prescription drugs covered by TRICARE. * **Quantity Limits:** Restrictions on the amount of medication you can receive per prescription (e.g., four pens per 28 days). * **Medical Necessity:** Documentation provided by a doctor proving a drug is required to treat a specific condition according to accepted medical standards. * **TRICARE Formulary Search Tool:** An online tool provided by Express Scripts to check the status and cost of specific drugs.
## Sources * **TRICARE.mil Pharmacy:** https://www.tricare.mil/pharmacy * **Express Scripts TRICARE Formulary Search:** https://www.express-scripts.com/frontend/open-enrollment/tricare/fst/ * **Defense Health Agency (DHA):** https://health.mil/ * **Humana Military (Region East):** https://www.humanamilitary.com/ * **TriWest Healthcare Alliance (Region West):** https://www.triwest.com/